Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.460
-0.040 (-2.67%)
Nov 6, 2026, 4:00 PM EST - Market closed
Health Catalyst Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Health Catalyst stock has a consensus rating of "Hold" and an average price target of $1.77. The average 1-year stock price forecast is 21.03% higher than the current stock price, while the lowest is $1.50 (+2.74%) and the highest is $2.00 (+36.99%).
Price Target: $1.77 (+21.03%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Sep 9, 2026.
Analyst Ratings
The average analyst rating for Health Catalyst stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 7 | 6 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 8 | 7 | 7 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.8 | Hold | Maintains | $1.8 | +23.29% | Sep 9, 2026 |
| BTIG | BTIG | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $1.75 → $1.5 | Hold | Reiterates | $1.75 → $1.5 | +2.74% | Aug 13, 2026 |
| Citi | Citi | Hold Reiterates $2.5 → $2 | Hold | Reiterates | $2.5 → $2 | +36.99% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
248.04M
from 311.14M
Decreased by -20.28%
Revenue Next Year
205.68M
from 248.04M
Decreased by -17.08%
EPS This Year
-0.06
from 0.18
EPS Next Year
-0.04
from -0.06
EPS and Forward PE are based on non-GAAP adjusted numbers.